1999
DOI: 10.1002/(sici)1099-081x(199901)20:1<53::aid-bdd157>3.0.co;2-p
|Get access via publisher |Summarize |Cite
Absolute bioavailability of reboxetine enantiomers and effect of gender on pharmacokinetics
Search citation statements
Paper Sections
Select...
33
3
3
3
Citation Types
1
29
0
1
Year Published
1999
2022
Publication Types
Select...
34
6
2
Relationship
2
40
Authors
Journals
Cited by 42 publications
(31 citation statements)
References 7 publications
1
29
0
1
“…Its absolute bioavailability is >94% (40). The administration of reboxetine with a high fat meal does not affect the extent of reboxetine absorption, but C max is reduced by approximately 20% (97).…”
Section: Absorption Distribution and Protein Bindingsupporting
confidence: 50%
“…Its absolute bioavailability is >94% (40). The administration of reboxetine with a high fat meal does not affect the extent of reboxetine absorption, but C max is reduced by approximately 20% (97).…”
Section: Absorption Distribution and Protein Bindingsupporting
confidence: 50%
“…The absolute bioavailability of reboxetine is >94%; therefore it does not undergo gut wall metabolism 17 . The effects of ketoconazole on reboxetine observed in this study are thus the result of inhibition of hepatic CYP3A4.…”
Section: Discussionmentioning
confidence: 70%
“…Sertraline C max was lower, and t 1/2 was shorter, in young males compared with the other groups [24,25]. A significantly lower C max for men compared with women (mean age, 24 years) has also been reported for single-dose reboxetine [26]. No elderly groups were included in that study.…”
Section: Discussionmentioning
confidence: 77%
“…Higher steady state plasma concentrations of duloxetine were observed in women compared with men in a population pharmacokinetic analysis; no interaction with age was reported [27]. Sex differences in antidepressant pharmacokinetics are commonly attributed to differences between men and women in body weight or body composition [25,26,28], or to sex or hormone differences in antidepressant metabolism by cytochrome P450 isoenzymes [22,27]. Age-related changes were observed in several pharmacokinetic parameters, including significant changes in mean AUC, C max , and weight-normalized Cl/F.…”
Section: Discussionmentioning
confidence: 91%
